Navigation Links
Intarcia Enrolls First Patients in "FREEDOM" Global Phase 3 Program for ITCA 650 in Type 2 Diabetes
Date:3/21/2013

therapeutic proteins and peptides at human body temperatures for extended periods of time.

Data from Intarcia's ITCA 650 Phase 2 program have demonstrated significant and sustained reductions in HbA1c and body weight over 48 weeks of treatment with a marked reduction in the GI adverse events typically associated with the self-injection products in this class. ITCA 650 is an investigational new therapy and is not currently approved by any regulatory authority. Exenatide, the active agent in ITCA 650, is a glucagon-like peptide-1 (GLP-1) receptor agonist currently marketed globally as twice-daily and once-weekly self-injection therapies for type 2 diabetes. Upon approval, ITCA 650 would represent the first injection-free GLP-1 therapy that can deliver a full year of treatment from a single placement. Intarcia's robust intellectual property portfolio protects ITCA 650 through 2031.

About Type 2 Diabetes

Every day, 5,225 new cases of diabetes are diagnosed in the U.S. alone, 90% to 95% of which are designated type 2 (T2D). T2D presents when the body either does not produce enough insulin or becomes resistant to insulin, resulting in high levels of blood sugar. The International Diabetes Federation estimates that 366 million adults worldwide suffered from T2D in 2011 and predicts this number will rise to 552 million by 2030; the Centers for Disease Control predicts that 25% to 33% of the U.S. adult population will have diabetes by 2050. It is estimated that pre-diabetes, or impaired glucose tolerance (IGT), a condition that often leads to diabetes, affects a population roughly twice the size of the current diabetes population. The World Health Organization estimates deaths resulting from diabetes will double between 2005 and 2030 and estimates the global cost of diabetes to have exceeded $400 billion in 2010. United Healthcare expects spending on diabetes and diabetes-related care to reach $500 billion by 2020 in the U.S. alone, and projects
'/>"/>

SOURCE Intarcia Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Intarcia Appoints Owen Hughes Chief Business Officer and Head of Corporate Development
2. ROX Medical enrolls first UK patients in CONTROL-HTN hypertension trial at Eastbourne General Hospital
3. ROX Medical enrolls first patients in Ireland for CONTROL-HTN hypertension trial at Beaumont and Mater Private Hospitals
4. Adynxx Enrolls First Patient in Phase 2 Proof-of-Concept Study for AYX1, Lead Compound for the Prevention of Post-Surgical Pain
5. Boehringer Ingelheim Enrolls First Patients in Pivotal Phase 3 Interferon-Free Hepatitis C Trial Program
6. CalHIPSO Enrolls Over 7,700 Providers in EHR Implementation Program, Hits Other Key Milestones After First Two Years
7. PQA and CECity Launch Joint Venture to Deliver First National Pharmacy Quality Measurement, Benchmarking and Reporting Platform for Pharmacies and Health Plans
8. First Patients Dosed in Proof-of-Concept Clinical Study of Alder Biopharmaceuticals Lead Therapeutic Candidate for Treatment of Migraine, ALD403
9. Johnson & Johnson to Host Analyst Conference Call on First-Quarter Results
10. Wyckoff Heights Medical Center Is First New York Hospital to Offer Asthmapolis Mobile Asthma Management Program
11. Quest Diagnostics Launches Dementia Diagnostic Panel, First in Industry for Treatable Forms of Cognitive Impairment Based on Medical Guidelines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/hmdflj/outlook_of_global ) ... Global Biologic Drug Discovery Outsourcing Market" report to ... outsourcing market will likely grow in a CAGR of ... B by 2020. It has been widely ... a new but important type of medication. They provide ...
(Date:7/7/2015)... LONDON , July 7, 2015 ... Sales Forecasts, Helping Your Influence  ,Are ... ? If so, now gain technological and commercial predictions ... authority. There explore trends in research and development, results, ... by visiongain shows you what,s possible for ...
(Date:7/7/2015)... , July 7, 2015  PAREXEL International Corporation (NASDAQ: ... Quarter and Fiscal Year 2015 on Wednesday, August 5 th ... announcement will be available on PAREXEL,s website at www.PAREXEL.com ... PAREXEL will host a conference call and live ... , 2015 to discuss the results.  To access the webcast, ...
Breaking Medicine Technology:Outlook of Global Biologic Drug Discovery Outsourcing Market to 2020 2Outlook of Global Biologic Drug Discovery Outsourcing Market to 2020 3Biobanking for Medicine: Technology, Industry and Market 2015-2025 2Biobanking for Medicine: Technology, Industry and Market 2015-2025 3Biobanking for Medicine: Technology, Industry and Market 2015-2025 4Biobanking for Medicine: Technology, Industry and Market 2015-2025 5Biobanking for Medicine: Technology, Industry and Market 2015-2025 6Biobanking for Medicine: Technology, Industry and Market 2015-2025 7Biobanking for Medicine: Technology, Industry and Market 2015-2025 8Biobanking for Medicine: Technology, Industry and Market 2015-2025 9Biobanking for Medicine: Technology, Industry and Market 2015-2025 10PAREXEL International Announces Date Of Fourth Quarter And Fiscal Year 2015 Earnings Release And Conference Call 2
... Carl Marks Advisory Group LLC, the investment banking ... been retained to act as financial advisor to Scovill ... products used in the apparel and industrial markets.  Scovill ... Marks is facilitating the sale of the company,s operations ...
... following is being released by SafeMinds ( www.SafeMinds.org ): ... has publicly denied a vaccine-autism link, while at the ... been awarding damages for vaccine injury to children with ... on verifiable government data, breaks ground in the controversial ...
Cached Medicine Technology:Carl Marks Advises Scovill Fasteners in Sale of Company 283 Cases of Autism Associated with Childhood Vaccine Injury Compensated in Federal Vaccine Court 2
(Date:7/7/2015)... ... July 08, 2015 , ... ... help today’s surgical services directors and business managers increase efficiency, reduce supply chain ... will be held at the Renaissance Phoenix Glendale, February 21-24, 2016. The agenda ...
(Date:7/7/2015)... ... July 08, 2015 , ... ... as a 2015-2016 inductee into its VIP Woman of the Year Circle. She ... nation’s leading networking organization exclusively for professional women, boasting more than 700,000 members ...
(Date:7/7/2015)... ... July 07, 2015 , ... World Patent Marketing, a vertically ... medical invention that prevents IV lines from getting entangled. , "The US ... worth $133 billion by 2016," says Scott Cooper, CEO and Creative Director of ...
(Date:7/7/2015)... CA (PRWEB) , ... July 07, 2015 , ... ... outlined a report from Cambridge Consultants that discussed how innovation and technology would ... article outlined the need to address issues of accessibility and affordability, especially in ...
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... ... Entertainment for sweetFrog to interact with fans and provide frozen yogurt offerings at ... the sweetFrog mobile truck will be on site at concerts throughout the summer ...
Breaking Medicine News(10 mins):Health News:Agenda, Pre-Conference Workshop, and More Announced for OR Business Management Conference 2Health News:Agenda, Pre-Conference Workshop, and More Announced for OR Business Management Conference 3Health News:National Association of Professional Women Inducts Jessica Goldstein, Vice President / Account Director at Discovery USA, Into its VIP Woman of the Year Circle 2Health News:New Evidence Shows Why Hospital Weekend Effect Is So Dangerous As World Patent Marketing Introduces A New Medical Invention 2Health News:New Evidence Shows Why Hospital Weekend Effect Is So Dangerous As World Patent Marketing Introduces A New Medical Invention 3Health News:New Evidence Shows Why Hospital Weekend Effect Is So Dangerous As World Patent Marketing Introduces A New Medical Invention 4Health News:New Evidence Shows Why Hospital Weekend Effect Is So Dangerous As World Patent Marketing Introduces A New Medical Invention 5Health News:Recent Article on Pharmaceutical Innovation Highlights the Need for Creative Solutions to Common Problems, Says Medlife Pharmacy 2Health News:Recent Article on Pharmaceutical Innovation Highlights the Need for Creative Solutions to Common Problems, Says Medlife Pharmacy 3Health News:sweetFrog Mobile Trucks to Offer Froyo at Live Nation Venues 2
... Scientists who have started to identify genes and pathways associated ... it,s a first step in the potential development of new ... 100 cigarettes over a lifetime -- account for about 10 ... lung cancer patients hasn,t been studied as much as smokers ...
... MONDAY, Jan. 9 (HealthDay News) -- A new study finds ... changes in people who have a well-known genetic risk factor. ... E (APOE) gene. "The presence of an APOE e4 ... disease, with a higher percentage of individuals with Alzheimer,s disease ...
... , MONDAY, Jan. 9 (HealthDay News) -- High ... in the number of people with private health insurance limited ... 3.9 percent in 2010, according to a new study. ... care or seek less expensive treatment, said researchers at the ...
... Doheny HealthDay Reporter , MONDAY, Jan. 9 ... menopause appear to increase their risk of developing diabetes, ... echoes findings of other studies linking the cholesterol-lowering drugs ... Statins include drugs such as Lipitor, Lescol and Mevacor. ...
... -- A 2010 outbreak of Legionnaires, disease in Wisconsin ... hospital lobby, according to a study published in the ... , the journal of the Society for Healthcare Epidemiology ... was detected among eight people in southeast Wisconsin, state ...
... rotor syndrome uncovered The main symptom of ... substance known as conjugated bilirubin. Bilirubin is a yellow substance ... cells. It is conjugated in the liver to make it ... the body. Although Rotor syndrome is known to be a ...
Cached Medicine News:Health News:Researchers Look at Genomes of Nonsmokers With Lung Cancer 2Health News:Exercise May Help Those at Higher Risk for Alzheimer's: Study 2Health News:Growth in U.S. Health Spending Stayed Slow in 2010 2Health News:Growth in U.S. Health Spending Stayed Slow in 2010 3Health News:Statins May Boost Diabetes Risk in Older Women 2Health News:Statins May Boost Diabetes Risk in Older Women 3Health News:Legionnaires' disease outbreak linked to hospital's decorative fountain 2Health News:JCI online early table of contents: Jan. 9, 2012 2Health News:JCI online early table of contents: Jan. 9, 2012 3Health News:JCI online early table of contents: Jan. 9, 2012 4Health News:JCI online early table of contents: Jan. 9, 2012 5Health News:JCI online early table of contents: Jan. 9, 2012 6Health News:JCI online early table of contents: Jan. 9, 2012 7
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: